CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript
CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.
Stay updated with breaking news from Caredx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.
Full Year Revenue Exceeds Guidance; Patent Litigation Impacts Net Loss
CareDx, Inc. – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare...
CareDx, Inc. – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and...
Dublin, Feb. 13, 2024 (GLOBE NEWSWIRE) -- The